TechnologyWall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.By Katherine LangfordMarketWatch
TechnologyInvestors’ search for safety has made toothpaste stocks more expensive than techBy Katherine LangfordMarketWatch
TechnologySpaceX’s quarterly revenue beats estimates as AI business surgesBy Marcus ChenGlobe and Mail Business